Information Center

Hold the project initiation demonstration meeting for the 1.1 category innovative traditional Chinese medicine BDP-ZS-001.

Release time:

2023-12-26 18:29

Nanjing Baidier Biopharmaceutical Co., Ltd. held a project approval meeting for the 1.1 category innovative traditional Chinese medicine BDP-ZS-001 on December 25, 2022.023The meeting was chaired by Professor Peng Guoping from Nanjing University of Traditional Chinese Medicine. Attendees included clinical experts, pharmacy professors, and investment bankers from the Dermatology Department of the Skin Disease Hospital (Institute) of the Chinese Academy of Medical Sciences, China Pharmaceutical University, Jiangsu Provincial Hospital of Traditional Chinese Medicine Dermatology, Nanjing Maternal and Child Health Hospital Dermatology, and Yida Equity Investment Fund Management Co., Ltd. Ms. Yu Min, General Manager of Nanjing Baidier Biopharmaceutical Co., Ltd., provided a comprehensive introduction to the research overview of this project and the origins of innovative traditional Chinese medicine focusing on skin inflammatory diseases. Participants discussed the market positioning, clinical research, pharmacology, efficacy, and safety evaluation of the innovative traditional Chinese medicine project, providing valuable feedback.

Through in-depth discussions among the experts, this meeting affirmed the project approval for the 1.1 category innovative traditional Chinese medicine BDP-ZS-001..


Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com

©2024 Zhejiang Kanova biopharmaceutical Co., LTD

Power by:300.cn  Beijing

Business License